Department of Neurology, Stroke/Neurocritical Care Division, Catholic Health System, Buffalo, New York, USA.
J Stroke Cerebrovasc Dis. 2010 Mar;19(2):110-5. doi: 10.1016/j.jstrokecerebrovasdis.2009.11.009.
A better prediction of the time course of symptomatic vasospasm (SVSP) might have a significant impact on the management and prevention of delayed neurologic ischemic deficit (DIND). We studied the influence of the treatment for ruptured aneurysm on SVSP timing. We retrospectively analyzed data of consecutive patients with aneurysmal subarachnoid hemorrhage (aSAH) admitted in our center between 1999 and 2005, treated within 72 hours of the rupture by surgical clipping or endovascular coiling and in accordance with our neuroscience unit protocol. We analyzed the presence of SVSP and recorded the timing of occurrence after the aneurysmal repair intervention. Data on demographics, premorbid conditions, time elapsed from the subarachnoid hemorrhage onset and intervention, and clinical and radiologic characteristics at admission were collected. The first occurrence of postintervention SVSP was recorded and compared between the 2 treatment groups using a proportional hazards regression model, including significant covariates. Of the 67 patients analyzed, 21 (31%) underwent endovascular coiling and 46 (69%) underwent surgical clipping. The baseline variables were similar in the 2 groups. The median time from the procedure to clinical vasospasm was 4 days in the coiled patients and 7 days in the clipped patients. In a proportional hazards model regression analysis including age, sex, Fisher and Hunt-Hess grades, time between onset to procedure, and intervention type, only intervention type emerged as a significant predictor of time to SVSP after intervention (likelihood ratio chi2 = 16.8; P < .00). Treatment modality of ruptured intracranial aneurysm may influence the timing of SVSP occurrence.
更准确地预测症状性血管痉挛(SVSP)的时间进程可能会对迟发性神经缺血性缺损(DIND)的管理和预防产生重大影响。我们研究了破裂动脉瘤的治疗对 SVSP 时间的影响。我们回顾性分析了 1999 年至 2005 年间在我们中心连续收治的破裂性蛛网膜下腔出血(aSAH)患者的数据,这些患者在破裂后 72 小时内接受了手术夹闭或血管内栓塞治疗,并符合我们神经科学部门的治疗方案。我们分析了 SVSP 的存在情况,并记录了动脉瘤修复干预后出现的时间。收集了人口统计学、预发病况、从蛛网膜下腔出血发作到干预的时间、入院时的临床和影像学特征等数据。记录了干预后首次出现 SVSP 的情况,并使用比例风险回归模型比较了 2 种治疗组之间的差异,包括有显著意义的协变量。在分析的 67 例患者中,21 例(31%)接受了血管内栓塞,46 例(69%)接受了手术夹闭。2 组患者的基线变量相似。在接受线圈治疗的患者中,从手术到临床血管痉挛的中位数时间为 4 天,在接受夹闭治疗的患者中为 7 天。在包括年龄、性别、Fisher 和 Hunt-Hess 分级、从发病到手术的时间和干预类型的比例风险回归模型分析中,只有干预类型是干预后 SVSP 发生时间的显著预测因素(似然比卡方=16.8;P<0.00)。破裂颅内动脉瘤的治疗方式可能会影响 SVSP 发生的时间。